Adaptor Protein 2-mediated Endocytosis of the β-secretase BACE1 is Dispensable for Amyloid Precursor Protein Processing
Overview
Molecular Biology
Authors
Affiliations
The β-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) is a transmembrane aspartyl protease that catalyzes the proteolytic processing of APP and other plasma membrane protein precursors. BACE1 cycles between the trans-Golgi network (TGN), the plasma membrane, and endosomes by virtue of signals contained within its cytosolic C-terminal domain. One of these signals is the DXXLL-motif sequence DISLL, which controls transport between the TGN and endosomes via interaction with GGA proteins. Here we show that the DISLL sequence is embedded within a longer [DE]XXXL[LI]-motif sequence, DDISLL, which mediates internalization from the plasma membrane by interaction with the clathrin-associated, heterotetrameric adaptor protein 2 (AP-2) complex. Mutation of this signal or knockdown of either AP-2 or clathrin decreases endosomal localization and increases plasma membrane localization of BACE1. Remarkably, internalization-defective BACE1 is able to cleave an APP mutant that itself cannot be delivered to endosomes. The drug brefeldin A reversibly prevents BACE1-catalyzed APP cleavage, ruling out that this reaction occurs in the endoplasmic reticulum (ER) or ER-Golgi intermediate compartment. Taken together, these observations support the notion that BACE1 is capable of cleaving APP in late compartments of the secretory pathway.
Wang J, Fourriere L, Gleeson P Biochem J. 2024; 481(19):1297-1325.
PMID: 39302110 PMC: 11555708. DOI: 10.1042/BCJ20240056.
Golgi defect as a major contributor to lysosomal dysfunction.
Akaaboune S, Wang Y Front Cell Dev Biol. 2024; 12:1386149.
PMID: 38721528 PMC: 11076776. DOI: 10.3389/fcell.2024.1386149.
AP2S1 regulates APP degradation through late endosome-lysosome fusion in cells and APP/PS1 mice.
Wen Q, Luo B, Xie X, Zhou G, Chen J, Song L Traffic. 2022; 24(1):20-33.
PMID: 36412210 PMC: 10107530. DOI: 10.1111/tra.12874.
Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer's Disease.
Espinoza S, Grunenwald F, Gomez W, Garcia F, Abarzua-Catalan L, Oyarce-Pezoa S Cells. 2022; 11(12).
PMID: 35740989 PMC: 9221152. DOI: 10.3390/cells11121860.
Ahmad T, Vullhorst D, Chaudhuri R, Guardia C, Chaudhary N, Karavanova I J Cell Biol. 2022; 221(7).
PMID: 35579602 PMC: 9118086. DOI: 10.1083/jcb.202110167.